Information updates

Walking the Allergy Tightrope

ASCIA welcomes the speech that was delivered today in the Australian Parliament House by Dr Katie Allen MP, in support of government investment into allergy and anaphylaxis, by creating a new National Allergy Council (NAC) and a new National Allergy Centre of Excellence (NACE).

The speech can be viewed at https://katieallen.com.au/category/speeches/

Implementing these recommendations from the Report on the Parliamentary Inquiry into Allergies and Anaphylaxis ‘Walking the allergy tightrope - Addressing the rise of allergies and anaphylaxis in Australia’ will result in significant improvements to the health of more than 5 million Australians with allergic disease, their families and the community, with immediate and long term impact. 

The new NAC and NACE would enable continued expansion of the National Allergy Strategy, a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), and expansion of the Centre for Food & Allergy Research (CFAR). 

The Parliamentary Inquiry Report was tabled on Monday 15 June 2020 in the Parliament of the Commonwealth of Australia.  

Walking the allergy tightrope - Allergies and Anaphylaxis Report

ASCIA welcomed the recommendations in the Report and the recognition of ASCIA’s pivotal and leading role in improving the care of Australians with allergic disease. ASCIA has thanked the Minister for Health, Hon Greg Hunt MP, the Committee Chair, Trent Zimmerman MP, Deputy Chair, Dr Mike Freelander MP, panel members including Dr Katie Allen MP, and the committee Secretariat for their excellent work in initiating and conducting the Parliamentary Inquiry.  

 

This news item was issued on 16 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.    

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia